中文简介

《外科肿瘤学年鉴》专门为所有专业的执业外科医生带来最新、最重要的发展，包括多学科的癌症护理和研究。每期都有关于多学科癌症护理、癌症患者外科护理以及临床相关癌症研究结果的原创文章；与癌症外科患者多学科管理相关的小型课程和研讨会；以及关于基础科学进步、手术进展、辅助治疗、癌症预防、康复以及涉及癌症患者的社会经济问题的教育评论。《外科肿瘤学年鉴》（ASO）通过交流研究和教育的进展，促进高质量的外科肿瘤学管理，这些研究和教育对于为癌症患者提供当代多学科护理具有重要意义。外科肿瘤学学会（SSO）和美国乳腺外科医师学会（ASO）的官方杂志，是全球外科肿瘤学研究和教育方面的选择杂志。《外科肿瘤学年鉴》的使命是：1）在全国和世界范围内代表和推进外科肿瘤学专业；2）促进最高质量的多学科患者护理和实践管理；3）使用印刷和电子媒体提供相关的癌症教育和研究培训材料；4）促进临床和转化癌症研究，重点是临床试验；5）促进外科受训人员的职业发展及其向学术和社区实践的过渡；6）促进与癌症外科患者有关的公共政策和患者宣传问题。

英文简介

Annals of Surgical Oncology is specifically designed to bring the latest, most significant developments involving multidisciplinary cancer care and research to the practicing surgeon from all specialties. Each issue features original articles on multidisciplinary cancer care, surgical care of the cancer patient, and results of clinically-relevant cancer research; mini-courses and symposia related to multidisciplinary management of surgical patients with cancer; and educational reviews about basic science advances, advances in surgery, adjuvant therapies, cancer prevention, rehabilitation, and socioeconomic issues involving the cancer patient.The Annals of Surgical Oncology (ASO) promotes high-quality surgical oncology management by communicating advances in research and education that are relevant and valuable to the provision of contemporary multidisciplinary care for patients with cancer.The official journal of the Society of Surgical Oncology (SSO) and the American Society of Breast Surgeons, ASO is the journal of choice of surgical oncologists worldwide regarding surgical oncology research and education.The mission of the Annals of Surgical Oncology is to serve its readers by 1) representing and advancing the profession of surgical oncology throughout the nation and the world; 2) promoting the highest quality multidisciplinary patient care and practice management; 3) providing relevant cancer education and research training materials using print and electronic media; 4) promoting clinical and translational cancer research, with an emphasis on clinical trials; 5) facilitating the career development of surgical trainees and their transition into academic and community-based practice; and 6) promoting public policy and patient advocacy issues related to surgical patient with cancer.